Literature DB >> 12786922

Assessing the severity of migraine: development of the MIGSEV scale.

Abdelkader El Hasnaoui1, Muriel Vray, Alain Richard, Fatima Nachit-Ouinekh, François Boureau.   

Abstract

OBJECTIVES: To identify items that serve to assess the severity of migraine with a high level of clinical and psychometric relevance and to combine these into a unitary severity scale.
BACKGROUND: Severity of migraine is an important determinant of patient quality of life and of health care resource utilization. Despite this, no validated method exists for measuring migraine severity.
METHODS: After selection from the medical literature items of potential relevance to the severity of migraine, consensus meetings led to a choice of items which subsequently were refined further on the basis of patient interviews. The psychometric properties of those items then were assessed in a survey involving 287 migraineurs. The methods used to test reliability and validity included test-retest, calculation of Cronbach alpha coefficient, analysis of factorial structure using principal components analysis, a comparison of the agreement between doctors' and patients' assessments, and correlation with a validated quality-of-life questionnaire. The most pertinent items revealed by the factorial analysis were combined in a unitary scale.
RESULTS: Seven items reflecting severity were identified by expert consensus. These were intensity of pain, tolerability, disability in daily activities, presence of nausea or vomiting, resistance to treatment, duration of attacks, and frequency of attacks. Principal components analysis identified 3 dimensions accounting for 65% of the overall variance related to intensity of attacks, resistance to treatment, and frequency of attacks. The internal consistency and the reproducibility of the items appeared quite satisfactory, and variations in these items were correlated with quality-of-life scores. The 4 items related to intensity of attacks were combined into a single scale with 3 response modalities.
CONCLUSIONS: The 3 dimensions identified by this investigation appeared medically relevant and to have good psychometric properties. The items on the intensity dimension can be used to generate a simple scale for assessing migraine attack severity.

Entities:  

Mesh:

Year:  2003        PMID: 12786922     DOI: 10.1046/j.1526-4610.2003.03105.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  19 in total

Review 1.  Why HURT? A review of clinical instruments for headache management.

Authors:  Dawn C Buse; C Mark Sollars; Timothy J Steiner; Rigmor H Jensen; Mohammed A Al Jumah; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 2.  Assessment of cognitive dysfunction during migraine attacks: a systematic review.

Authors:  Raquel Gil-Gouveia; António G Oliveira; Isabel Pavão Martins
Journal:  J Neurol       Date:  2014-12-27       Impact factor: 4.849

3.  Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women.

Authors:  Siri Amundsen; Torunn G Øvrebø; Netta Marie S Amble; Anne Christine Poole; Hedvig Nordeng
Journal:  Eur J Clin Pharmacol       Date:  2016-09-13       Impact factor: 2.953

4.  Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.

Authors:  André Pradalier; Jean-Paul Auray; Abdelkader El Hasnaoui; Kazem Alzahouri; Jean-François Dartigues; Gérard Duru; Patrick Henry; Michel Lantéri-Minet; Christian Lucas; Guy Chazot; Anne-François Gaudin
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  Prenatal triptan exposure and parent-reported early childhood neurodevelopmental outcomes: an application of propensity score calibration to adjust for unmeasured confounding by migraine severity.

Authors:  Mollie E Wood; Jean A Frazier; Hedvig M E Nordeng; Kate L Lapane
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-11-11       Impact factor: 2.890

Review 6.  [Tools for assessing patient perception of the impact of migraine].

Authors:  Abdelkader El Hasnaoui; Adam Doble; Anne-Françoise Gaudin
Journal:  CNS Drugs       Date:  2006       Impact factor: 6.497

7.  Headache Impact Test-6 (HIT-6) scores for migraine patients: Their relation to disability as measured from a headache diary.

Authors:  Hae Eun Shin; Jeong Wook Park; Yeong In Kim; Kwang Soo Lee
Journal:  J Clin Neurol       Date:  2008-12-31       Impact factor: 3.077

8.  The psychometric properties of the persian migraine-specific quality of life questionnaire version 2.1 in episodic and chronic migraines.

Authors:  Alireza Zandifar; Samaneh Sadat Masjedi; Faraidoon Haghdoost; Fatemeh Asgari; Navid Manouchehri; Mahboobeh Banihashemi; Mohammad Reza Najafi; Abbas Ghorbani; Behzad Zolfaghari; Ali Gholamrezaei; Vahid Shaygannejad; Mohammad Saadatnia
Journal:  ScientificWorldJournal       Date:  2013-08-27

9.  Reliability and validity of the migraine disability assessment scale among migraine and tension type headache in Iranian patients.

Authors:  Alireza Zandifar; Fatemeh Asgari; Faraidoon Haghdoost; Samaneh Sadat Masjedi; Navid Manouchehri; Mahboobeh Banihashemi; Abbas Ghorbani; Mohammad Reza Najafi; Mohammad Saadatnia; Richard B Lipton
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

10.  A universal outcome measure for headache treatments, care-delivery systems and economic analysis.

Authors:  Timothy J Steiner; Mattias Linde; Petra Schnell-Inderst
Journal:  J Headache Pain       Date:  2021-07-01       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.